<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="news"><?OLF?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Immunogenetics</journal-id><journal-id journal-id-type="iso-abbrev">Immunogenetics</journal-id><journal-title-group><journal-title>Immunogenetics</journal-title></journal-title-group><issn pub-type="ppub">0093-7711</issn><issn pub-type="epub">1432-1211</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7186185</article-id><article-id pub-id-type="publisher-id">1165</article-id><article-id pub-id-type="doi">10.1007/s00251-020-01165-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Hypothesis</subject></subj-group></article-categories><title-group><article-title>COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>de Groot</surname><given-names>Natasja G.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Bontrop</surname><given-names>Ronald E.</given-names></name><address><email>bontrop@bprc.nl</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.11184.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0625 2495</institution-id><institution>Department of Comparative Genetics &#x00026; Refinement, </institution><institution>Biomedical Primate Research Centre, </institution></institution-wrap>Lange Kleiweg, 161 Rijswijk, The Netherlands </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>4</month><year>2020</year></pub-date><fpage>1</fpage><lpage>3</lpage><permissions><copyright-statement>&#x000a9; Springer-Verlag GmbH Germany, part of Springer Nature 2020</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions></article-meta></front><body><p id="Par1">Humankind is currently confronting a new type of coronavirus, and it may take considerable time before the human population and the virus arrive at a mutual equilibrium. The first patients with coronavirus disease 2019 (COVID-19) were recorded in December 2019 in China (Zhu et al. <xref ref-type="bibr" rid="CR29">2020</xref>), and since then the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally. Other reputed members of the coronavirus family are SARS-CoV-1 and MERS-CoV, which caused zoonotic events that resulted in epidemics in 2002 and 2012, respectively (Peiris et al. <xref ref-type="bibr" rid="CR18">2003</xref>; Zaki et al. <xref ref-type="bibr" rid="CR28">2012</xref>). According to the WHO (22/4/2020), more than 2,400,000 individuals have been infected by SARS-CoV-2, and at least 165,000 have succumbed to the disease (<ext-link ext-link-type="uri" xlink:href="https://covid19.who.int">https://covid19.who.int</ext-link>). Most patients with COVID-19 suffer from severe respiratory problems, and elderly people in particular or persons with comorbidities seem to be at greatest risk (Wang et al. <xref ref-type="bibr" rid="CR26">2020</xref>). The fatality rates for males are two to three times higher than for females (Porcheddu et al. <xref ref-type="bibr" rid="CR20">2020</xref>), but seem to fluctuate depending on the territory and demography of the population. Gender-related social factors, immunological differences, hormonal disparaties, and lifestyle habits such as smoking and alcohol consumption are considered to play a role (Wenham et al. <xref ref-type="bibr" rid="CR27">2020</xref>). The vulnerability of the male population with regard to the COVID-19 pandemic may to some extent be a result of gender-defined genetic polymorphisms.</p><p id="Par2">At least two coronaviruses use Angiotensin Converting Enzyme 2 as port of entry (ACE-2) to infect the host (Hoffmann et al. <xref ref-type="bibr" rid="CR11">2020</xref>; Kuba et al. <xref ref-type="bibr" rid="CR13">2005</xref>). ACE2 plays an important role in controlling blood pressure and regulating cardiac function, and is abundantly present on the epithelial cells of the lung, heart, blood vessels, kidneys, and intestines. Although the gene for ACE2 is located on the female sex chromosome, its location and polymorphisms do not seem to have had a bearing on the poor prognosis for male patients during the SARS-CoV-1 epidemic (Chiu et al. <xref ref-type="bibr" rid="CR4">2004</xref>).</p><p id="Par3">Another group of promising candidates could be genes involved in immunity. One of the prominent families that senses infection, and that is essential to the innate immune system, comprises the Toll-like receptors (TLR) (Akira and Takeda <xref ref-type="bibr" rid="CR1">2004</xref>). In humans, there are 10 different members, and each of them can be activated by different types of ligands stemming from disparate pathogens. TLR often act in the form of homo- or heterodimers, and play a role in clearing infections. Some TLR types are expressed on the cell surface, but the ones present on intracellular membranes of endosomes (TLR3, 7, 8, and 9) are intended to register, though not exclusively, viral infections by detecting foreign types of nucleic acids (Fitzgerald and Kagan <xref ref-type="bibr" rid="CR8">2020</xref>). The nuclear material of coronaviruses is single-stranded RNA (ssRNA). TLR3 and 9 interact with double-stranded viral RNA and unmethylated CpG DNA from bacteria and viruses, respectively (Parker et al. <xref ref-type="bibr" rid="CR17">2007</xref>). TLR3 may respond to infections by the West Nile virus &#x02013; also an ssRNA virus &#x02013; in a rodent model (Wang et al. <xref ref-type="bibr" rid="CR24">2004</xref>). In contrast to TLR3 and 9, the structurally related TLR7 and 8 tandem is encoded by the female X chromosome (Armant and Fenton <xref ref-type="bibr" rid="CR2">2002</xref>). Therefore, these latter two genes may represent gender-related risk factors. The prominent ligand for TLR7 and 8 is viral ssRNA (Diebold et al. <xref ref-type="bibr" rid="CR7">2004</xref>; Heil et al. <xref ref-type="bibr" rid="CR10">2004</xref>) and, more specifically for TLR8, its RNAse T2 degredation products (Greulich et al. <xref ref-type="bibr" rid="CR9">2019</xref>). In humans, TLR7 is constitutively expressed on the membranes of endosomes in plasmacytoid dendritic cells (DC) and B lymphocytes, whereas TLR8 is more prominently present in cells of the myeloid lineage such as monocytes and neutrophils (Hornung et al. <xref ref-type="bibr" rid="CR12">2002</xref>). TLR7-positive plamacytoid cells are copiously present in lung tissue (Plantinga et al. <xref ref-type="bibr" rid="CR19">2010</xref>). Upon activation of the TLR7 pathway, for instance by the influenza virus, plasmacytoid DC have the capacity to produce significant amounts of type I interferon (Di Domizio et al. <xref ref-type="bibr" rid="CR6">2009</xref>). Moreover, TLR8 is present in the lung, and is known to act upon infection by various viruses (Beignon et al. <xref ref-type="bibr" rid="CR3">2005</xref>; Heil et al. <xref ref-type="bibr" rid="CR10">2004</xref>). An immune response activated via the TLR7 and/or 8 pathway may also induce unwanted side effects. SARS-Cov-1, for instance, may induce a cytokine storm (Tang et al. <xref ref-type="bibr" rid="CR23">2016</xref>), and the viral activation of neutrophils in the case of asthma may result in lung pathology (Li et al. <xref ref-type="bibr" rid="CR14">2013</xref>). One of the two female sex chromosomes is generally inactivated in females (Lyon <xref ref-type="bibr" rid="CR15">1992</xref>; Schurz et al. <xref ref-type="bibr" rid="CR21">2019</xref>). In female immune cells, however, TLR7 genes &#x02013; and probably TLR8 &#x02013; escape such silencing. As a consequence, the genetic information on both chromosomes is expressed, whereas male individuals possess only a single copy of the X chromosome (Souyris et al. <xref ref-type="bibr" rid="CR22">2018</xref>). Gender-related expression profiles may result in a prominent dosage effect in which females are more prone to activate an immune response to single-stranded viruses such as SARS-CoV-2. Furthermore, the induction of cytokine profiles seems also to be dose dependent on the amount of genetic material delivered by the virus (Tang et al. <xref ref-type="bibr" rid="CR23">2016</xref>).</p><p id="Par4">This gender-determined dosage effect, however, is probably not the whole story. The TLR7 and 8 genes display copy number variation (CNV) in the population (Wang et al. <xref ref-type="bibr" rid="CR25">2014</xref>). In addition, TLR genes display allelic polymorphisms (Menendez et al. <xref ref-type="bibr" rid="CR16">2019</xref>; Wang et al. <xref ref-type="bibr" rid="CR25">2014</xref>) that may influence the strength of the interaction with their respective ligands or the quality of the ensuing signal that is transduced to the nucleus. There is ample proof that gender-based CNV of TLR7 has medical implications. The best-documented example is provided by systemic lupus erythematosus (SLE), a disorder in which the immune system attacks healthy tissue. This disease is far more prominent in females than in males, and the risk of developing SLE is associated with a higher copy number load of TLR7 (Deane et al. <xref ref-type="bibr" rid="CR5">2007</xref>; Wang et al. <xref ref-type="bibr" rid="CR25">2014</xref>). As a result, TLR7-related CNV may act as a two-edged sword. A high copy number load of TLR7 may guarantee a better protective response to ssRNA viruses, but it may also suggest a poor prognosis for individuals who are at risk of developing SLE. One has to realize, however, that CNV of TLR genes was not selected in nature to foster autoimmune-related disease &#x02013; its biological role in controlling virus irradication is likely to be more relevant. Therefore, it seems worthwhile to start documenting the types of TLR7 and 8 polymorphisms in different well-defined populations/cohorts that have been affected by COVID-19. Knowledge regarding the mechanisms of disease pathology may be applicable not only in future vaccine development (the constitution and dosage of vaccine components for males versus females) but also with respect to the route by which such a vaccine should be administered (local versus systemic).</p></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors are grateful to Donna Devine for editorial support.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name></person-group><article-title>Toll-like receptor signalling</article-title><source>Nat Rev Immunol</source><year>2004</year><volume>4</volume><fpage>499</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1038/nri1391</pub-id><?supplied-pmid 15229469?><pub-id pub-id-type="pmid">15229469</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armant</surname><given-names>MA</given-names></name><name><surname>Fenton</surname><given-names>MJ</given-names></name></person-group><article-title>Toll-like receptors: a family of pattern-recognition receptors in mammals</article-title><source>Genome Biol</source><year>2002</year><volume>3</volume><fpage>REVIEWS3011</fpage><pub-id pub-id-type="doi">10.1186/gb-2002-3-8-reviews3011</pub-id><?supplied-pmid 12186654?><pub-id pub-id-type="pmid">12186654</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beignon</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions</article-title><source>J Clin Invest</source><year>2005</year><volume>115</volume><fpage>3265</fpage><lpage>3275</lpage><pub-id pub-id-type="doi">10.1172/JCI26032</pub-id><?supplied-pmid 16224540?><pub-id pub-id-type="pmid">16224540</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>RW</given-names></name><etal/></person-group><article-title>ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome</article-title><source>Clin Chem</source><year>2004</year><volume>50</volume><fpage>1683</fpage><lpage>1686</lpage><pub-id pub-id-type="doi">10.1373/clinchem.2004.035436</pub-id><?supplied-pmid 15331509?><pub-id pub-id-type="pmid">15331509</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deane</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation</article-title><source>Immunity</source><year>2007</year><volume>27</volume><fpage>801</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.09.009</pub-id><?supplied-pmid 17997333?><pub-id pub-id-type="pmid">17997333</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Domizio</surname><given-names>J</given-names></name><name><surname>Blum</surname><given-names>A</given-names></name><name><surname>Gallagher-Gambarelli</surname><given-names>M</given-names></name><name><surname>Molens</surname><given-names>JP</given-names></name><name><surname>Chaperot</surname><given-names>L</given-names></name><name><surname>Plumas</surname><given-names>J</given-names></name></person-group><article-title>TLR7 stimulation in human plasmacytoid dendritic cells leads to the induction of early IFN-inducible genes in the absence of type I IFN</article-title><source>Blood</source><year>2009</year><volume>114</volume><fpage>1794</fpage><lpage>1802</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-04-216770</pub-id><?supplied-pmid 19553637?><pub-id pub-id-type="pmid">19553637</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diebold</surname><given-names>SS</given-names></name><name><surname>Kaisho</surname><given-names>T</given-names></name><name><surname>Hemmi</surname><given-names>H</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Reis e Sousa</surname><given-names>C</given-names></name></person-group><article-title>Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA</article-title><source>Science</source><year>2004</year><volume>303</volume><fpage>1529</fpage><lpage>1531</lpage><pub-id pub-id-type="doi">10.1126/science.1093616</pub-id><?supplied-pmid 14976261?><pub-id pub-id-type="pmid">14976261</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>KA</given-names></name><name><surname>Kagan</surname><given-names>JC</given-names></name></person-group><article-title>Toll-like receptors and the control of immunity</article-title><source>Cell</source><year>2020</year><volume>180</volume><fpage>1044</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.02.041</pub-id><?supplied-pmid 32164908?><pub-id pub-id-type="pmid">32164908</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greulich</surname><given-names>W</given-names></name><etal/></person-group><article-title>TLR8 is a sensor of RNase T2 degradation products</article-title><source>Cell</source><year>2019</year><volume>179</volume><issue>1264&#x02013;1275</issue><fpage>e1213</fpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.11.001</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heil</surname><given-names>F</given-names></name><etal/></person-group><article-title>Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8</article-title><source>Science</source><year>2004</year><volume>303</volume><fpage>1526</fpage><lpage>1529</lpage><pub-id pub-id-type="doi">10.1126/science.1093620</pub-id><?supplied-pmid 14976262?><pub-id pub-id-type="pmid">14976262</pub-id></element-citation></ref><ref id="CR11"><mixed-citation publication-type="other">Hoffmann M et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 10.1016/j.cell.2020.02.052</mixed-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornung</surname><given-names>V</given-names></name><etal/></person-group><article-title>Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><fpage>4531</fpage><lpage>4537</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.168.9.4531</pub-id><?supplied-pmid 11970999?><pub-id pub-id-type="pmid">11970999</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuba</surname><given-names>K</given-names></name><etal/></person-group><article-title>A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury</article-title><source>Nat Med</source><year>2005</year><volume>11</volume><fpage>875</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1038/nm1267</pub-id><?supplied-pmid 7095783?><pub-id pub-id-type="pmid">16007097</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name></person-group><article-title>Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response</article-title><source>Microbes Infect</source><year>2013</year><volume>15</volume><fpage>88</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2012.10.008</pub-id><?supplied-pmid 23123977?><pub-id pub-id-type="pmid">23123977</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname><given-names>MF</given-names></name></person-group><article-title>Some milestones in the history of X-chromosome inactivation</article-title><source>Annu Rev Genet</source><year>1992</year><volume>26</volume><fpage>16</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1146/annurev.ge.26.120192.000313</pub-id><?supplied-pmid 1482111?><pub-id pub-id-type="pmid">1482111</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menendez</surname><given-names>D</given-names></name><etal/></person-group><article-title>p53-responsive TLR8 SNP enhances human innate immune response to respiratory syncytial virus</article-title><source>J Clin Invest</source><year>2019</year><volume>129</volume><fpage>4875</fpage><lpage>4884</lpage><pub-id pub-id-type="doi">10.1172/JCI128626</pub-id><?supplied-pmid 31430261?><pub-id pub-id-type="pmid">31430261</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>LC</given-names></name><name><surname>Prince</surname><given-names>LR</given-names></name><name><surname>Sabroe</surname><given-names>I</given-names></name></person-group><article-title>Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity</article-title><source>Clin Exp Immunol</source><year>2007</year><volume>147</volume><fpage>199</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03203.x</pub-id><?supplied-pmid 17223959?><pub-id pub-id-type="pmid">17223959</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study</article-title><source>Lancet</source><year>2003</year><volume>361</volume><fpage>1767</fpage><lpage>1772</lpage><pub-id pub-id-type="doi">10.1016/s0140-6736(03)13412-5</pub-id><?supplied-pmid 12781535?><pub-id pub-id-type="pmid">12781535</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plantinga</surname><given-names>M</given-names></name><name><surname>Hammad</surname><given-names>H</given-names></name><name><surname>Lambrecht</surname><given-names>BN</given-names></name></person-group><article-title>Origin and functional specializations of DC subsets in the lung</article-title><source>Eur J Immunol</source><year>2010</year><volume>40</volume><fpage>2112</fpage><lpage>2118</lpage><pub-id pub-id-type="doi">10.1002/eji.201040562</pub-id><?supplied-pmid 20853496?><pub-id pub-id-type="pmid">20853496</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porcheddu</surname><given-names>R</given-names></name><name><surname>Serra</surname><given-names>C</given-names></name><name><surname>Kelvin</surname><given-names>D</given-names></name><name><surname>Kelvin</surname><given-names>N</given-names></name><name><surname>Rubino</surname><given-names>S</given-names></name></person-group><article-title>Similarity in case fatality rates (CFR) of COVID-19/SARS-COV-2 in Italy and China</article-title><source>J Infect Dev Ctries</source><year>2020</year><volume>14</volume><fpage>125</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.3855/jidc.12600</pub-id><?supplied-pmid 32146445?><pub-id pub-id-type="pmid">32146445</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schurz</surname><given-names>H</given-names></name><name><surname>Salie</surname><given-names>M</given-names></name><name><surname>Tromp</surname><given-names>G</given-names></name><name><surname>Hoal</surname><given-names>EG</given-names></name><name><surname>Kinnear</surname><given-names>CJ</given-names></name><name><surname>Moller</surname><given-names>M</given-names></name></person-group><article-title>The X chromosome and sex-specific effects in infectious disease susceptibility</article-title><source>Hum Genomics</source><year>2019</year><volume>13</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.1186/s40246-018-0185-z</pub-id><?supplied-pmid 30621780?><pub-id pub-id-type="pmid">30621780</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souyris</surname><given-names>M</given-names></name><etal/></person-group><article-title>TLR7 escapes X chromosome inactivation in immune cells</article-title><source>Sci Immunol</source><year>2018</year><volume>3</volume><fpage>eaap8855</fpage><pub-id pub-id-type="doi">10.1126/sciimmunol.aap8855</pub-id><?supplied-pmid 29374079?><pub-id pub-id-type="pmid">29374079</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>FS</given-names></name><etal/></person-group><article-title>Differential neutrophil activation in viral infections: enhanced TLR-7/8-mediated CXCL8 release in asthma</article-title><source>Respirology</source><year>2016</year><volume>21</volume><fpage>172</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1111/resp.12657</pub-id><?supplied-pmid 26477783?><pub-id pub-id-type="pmid">26477783</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Town</surname><given-names>T</given-names></name><name><surname>Alexopoulou</surname><given-names>L</given-names></name><name><surname>Anderson</surname><given-names>JF</given-names></name><name><surname>Fikrig</surname><given-names>E</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group><article-title>Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis</article-title><source>Nat Med</source><year>2004</year><volume>10</volume><fpage>1366</fpage><lpage>1373</lpage><pub-id pub-id-type="doi">10.1038/nm1140</pub-id><?supplied-pmid 15558055?><pub-id pub-id-type="pmid">15558055</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Genetic variations in toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population</article-title><source>Sci Rep</source><year>2014</year><volume>4</volume><fpage>3792</fpage><pub-id pub-id-type="doi">10.1038/srep03792</pub-id><?supplied-pmid 24445780?><pub-id pub-id-type="pmid">24445780</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Du</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>An</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>B</given-names></name></person-group><article-title>Comorbidities and multi-organ injuries in the treatment of COVID-19</article-title><source>Lancet</source><year>2020</year><volume>395</volume><fpage>e52</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30558-4</pub-id><?supplied-pmid 32171074?><pub-id pub-id-type="pmid">32171074</pub-id></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenham</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Morgan</surname><given-names>R</given-names></name><collab>Gender Group C-W</collab></person-group><article-title>COVID-19: the gendered impacts of the outbreak</article-title><source>Lancet</source><year>2020</year><volume>395</volume><fpage>846</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30526-2</pub-id><?supplied-pmid 32151325?><pub-id pub-id-type="pmid">32151325</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaki</surname><given-names>AM</given-names></name><name><surname>van Boheemen</surname><given-names>S</given-names></name><name><surname>Bestebroer</surname><given-names>TM</given-names></name><name><surname>Osterhaus</surname><given-names>AD</given-names></name><name><surname>Fouchier</surname><given-names>RA</given-names></name></person-group><article-title>Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</article-title><source>N Engl J Med</source><year>2012</year><volume>367</volume><fpage>1814</fpage><lpage>1820</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1211721</pub-id><?supplied-pmid 23075143?><pub-id pub-id-type="pmid">23075143</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>N</given-names></name><etal/></person-group><article-title>A novel coronavirus from patients with pneumonia in China, 2019</article-title><source>N Engl J Med</source><year>2020</year><volume>382</volume><fpage>727</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2001017</pub-id><?supplied-pmid 31978945?><pub-id pub-id-type="pmid">31978945</pub-id></element-citation></ref></ref-list></back></article>